FDA rejects Amphastar's nasal version of opioid overdose treatment
FOX News
Amphastar Pharmaceuticals Inc said on Tuesday that the U.S. Food and Drug Administration had rejected its application to market an intranasal version of the drug naloxone, which is designed to stop or reverse the effects of an opioid overdose.
Whether you’re finding your inner zen or just hankering for something healthy, the answer can be found within your Buddha bowl.
BBC News - Health
After the actress ate a spider's leg, we look at whether the UK should embrace eating insects.
CBC | Health News
Pincher Creek has one of the highest rates of childhood immunization in Alberta but Fort Macleod, just down the road, ranks nearly dead last.
No comments:
Post a Comment